Home / Company / News

新闻

Latest press coverage

All Press Coverage

Forbes: 采用模型引导的药物开发可提高制药业的投资回报率

如何利用建模支持 FDA 批准一种外用非专利药物产品

Pharma Exec: MDMA Therapy for Mental Health Conditions

Featured press coverage

All Press Coverage

How can the industry balance the need for faster drug approvals with the necessity of ensuring patient safety and efficacy?

Certara’s Steve Sibley, Vice President Regulatory Strategy, is quoted in this Pharma's Almanac article about the challenges of balancing faster drug approvals with patient…

Featured press release

All Press Release

Certara 2025 年第一季度财务业绩报告

RADNOR, PA— 2025 年 5 月 5 日-- Certara, Inc. （纳斯达克股票代码：CERT), a global leader in model-informed drug development, today reported its financial results for the first quarter…

Latest press releases

All Press Release

Certara 将参加即将举行的投资者会议

Certara 推出 Non-Animal Navigator™ 解决方案，助力药物开发者减少对动物试验的依赖

Certara Reports Preliminary First Quarter 2025 Financial Results Announces $100 Million Share Repurchase Authorization

Recent Announcements

All Announcement

Certara Earns Great Place to Work Certification™ for Fourth Consecutive Year

Certara 举办 Second Annual Certainty U.S. 活动

Certara 与 A2Healthcare 加速模型引导的药物开发（MIDD）在日本的落地应用

Certara 与 Biowaived 达成战略合作，强化生物制药能力

Certara 获欧洲药品管理局项目授权，评估 CAR-T 细胞疗法的真实世界数据环境

Certara 任命生物统计、数据科学与准入部门新负责人

All news

Certara 收购了 Vyasa，这是一家提供预测服务，以加速科学创新的人工智能公司

pre-update, Press Release

Certara Announces the Completion of Arsenal Capital Partners’ Investment and the Appointment of David Spaight to the Board of Directors

pre-update, Press Release

Project Optimus: How to Prepare for Success

pre-update, Press Coverage

Arsenal Capital Partners Increases Investment in Global Biosimulation Leader Certara with $449M Stock Purchase

pre-update, Press Release

Accelerating Market Access with Data-Driven Payer Engagement

pre-update, Press Coverage

Simultaneous FDA & EMA Submissions for Drug Approvals

pre-update, Press Coverage

Certara Announces New Release of PK Submit

pre-update, Announcement

Certara Hosts Seminar on Drug Discovery Challenges in Japan and How Modeling and Simulation Can Solve Them

pre-update, Press Coverage

Certara to Report Second Quarter 2022 Financial Results on August 9th, 2022

pre-update, Press Release

Utilizing Pharmacokinetic and Pharmacodynamic Modeling & Simulation Technologies for Anesthesiology and Pain Medicine

pre-update, Press Coverage

Certara Earns 2022 Great Place to Work Certification™

pre-update, Announcement

P21 Adds Support for CDISC Open Rules Engine (CORE)

Certara Products, Certara Products - Pinnacle 21, pre-update, Announcement

‹
1
……
9
10
11
12
13
……
15
›

Be the first to get the latest

Transforming drug development is not just our goal—it’s our obsession. 如果这也是您的想法，那么请第一时间了解新见解，与我们一起推动科学发展。

© 2025 Certara. 保留所有权力。 | 隐私政策

沪ICP备2022021526号

Powered by Translations.com GlobalLink Web Software